307 related articles for article (PubMed ID: 36430293)
1. Targeting Oncogenic Rewiring of Lipid Metabolism for Glioblastoma Treatment.
Lee H; Kim D; Youn B
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430293
[TBL] [Abstract][Full Text] [Related]
2. The Glioblastoma Microenvironment: Morphology, Metabolism, and Molecular Signature of Glial Dynamics to Discover Metabolic Rewiring Sequence.
Virtuoso A; Giovannoni R; De Luca C; Gargano F; Cerasuolo M; Maggio N; Lavitrano M; Papa M
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33804873
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Contrasts: Fatty Acid Oxidation and Ketone Bodies in Healthy Brains vs. Glioblastoma Multiforme.
Tamas C; Tamas F; Kovecsi A; Cehan A; Balasa A
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791520
[TBL] [Abstract][Full Text] [Related]
4. Lipid accumulation and oxidation in glioblastoma multiforme.
Taïb B; Aboussalah AM; Moniruzzaman M; Chen S; Haughey NJ; Kim SF; Ahima RS
Sci Rep; 2019 Dec; 9(1):19593. PubMed ID: 31863022
[TBL] [Abstract][Full Text] [Related]
5. Beyond glucose: alternative sources of energy in glioblastoma.
Caniglia JL; Jalasutram A; Asuthkar S; Sahagun J; Park S; Ravindra A; Tsung AJ; Guda MR; Velpula KK
Theranostics; 2021; 11(5):2048-2057. PubMed ID: 33500708
[TBL] [Abstract][Full Text] [Related]
6. VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties.
Arif T; Krelin Y; Nakdimon I; Benharroch D; Paul A; Dadon-Klein D; Shoshan-Barmatz V
Neuro Oncol; 2017 Jul; 19(7):951-964. PubMed ID: 28339833
[TBL] [Abstract][Full Text] [Related]
7. Altered Metabolism in Glioblastoma: Myeloid-Derived Suppressor Cell (MDSC) Fitness and Tumor-Infiltrating Lymphocyte (TIL) Dysfunction.
Di Ianni N; Musio S; Pellegatta S
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923299
[TBL] [Abstract][Full Text] [Related]
8. Bioengineered Models to Study Microenvironmental Regulation of Glioblastoma Metabolism.
Chen J; Lee H; Schmitt P; Choy CJ; Miller DM; Williams BJ; Bearer EL; Frieboes HB
J Neuropathol Exp Neurol; 2021 Nov; 80(11):1012–1023. PubMed ID: 34524448
[TBL] [Abstract][Full Text] [Related]
9. Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma.
Zhang H; Zhou Y; Cui B; Liu Z; Shen H
Biomed Pharmacother; 2020 Jun; 126():110086. PubMed ID: 32172060
[TBL] [Abstract][Full Text] [Related]
10. Targeting dysregulated lipid metabolism in the tumor microenvironment.
Kim DH; Song NY; Yim H
Arch Pharm Res; 2023 Dec; 46(11-12):855-881. PubMed ID: 38060103
[TBL] [Abstract][Full Text] [Related]
11. Myeloid Cells in Glioblastoma Microenvironment.
De Leo A; Ugolini A; Veglia F
Cells; 2020 Dec; 10(1):. PubMed ID: 33374253
[TBL] [Abstract][Full Text] [Related]
12. Transcription factors in glioblastoma - Molecular pathogenesis and clinical implications.
Papavassiliou KA; Papavassiliou AG
Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188667. PubMed ID: 34894431
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities.
Wang G; Zhong K; Wang Z; Zhang Z; Tang X; Tong A; Zhou L
Front Immunol; 2022; 13():964898. PubMed ID: 35967394
[TBL] [Abstract][Full Text] [Related]
14. Local Targeting of NAD
Li M; Kirtane AR; Kiyokawa J; Nagashima H; Lopes A; Tirmizi ZA; Lee CK; Traverso G; Cahill DP; Wakimoto H
Cancer Res; 2020 Nov; 80(22):5024-5034. PubMed ID: 32998997
[TBL] [Abstract][Full Text] [Related]
15. Multifaceted Functional Role of Semaphorins in Glioblastoma.
Angelucci C; Lama G; Sica G
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31052281
[TBL] [Abstract][Full Text] [Related]
16. Glioblastoma: Targeting the autophagy in tumorigenesis.
Yang K; Niu L; Bai Y; Le W
Brain Res Bull; 2019 Nov; 153():334-340. PubMed ID: 31580908
[TBL] [Abstract][Full Text] [Related]
17. Glioblastoma precision therapy: From the bench to the clinic.
Zhou Y; Wu W; Bi H; Yang D; Zhang C
Cancer Lett; 2020 Apr; 475():79-91. PubMed ID: 32004571
[TBL] [Abstract][Full Text] [Related]
18. Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.
Poli A; Wang J; Domingues O; Planagumà J; Yan T; Rygh CB; Skaftnesmo KO; Thorsen F; McCormack E; Hentges F; Pedersen PH; Zimmer J; Enger PØ; Chekenya M
Oncotarget; 2013 Sep; 4(9):1527-46. PubMed ID: 24127551
[TBL] [Abstract][Full Text] [Related]
19. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
[TBL] [Abstract][Full Text] [Related]
20. Involvement of Intracellular Cholesterol in Temozolomide-Induced Glioblastoma Cell Death.
Yamamoto Y; Sasaki N; Kumagai K; Takeuchi S; Toyooka T; Otani N; Wada K; Narita Y; Ichimura K; Namba H; Mori K; Tomiyama A
Neurol Med Chir (Tokyo); 2018 Jul; 58(7):296-302. PubMed ID: 29899179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
